Lineage Cell Therapeutics Inc (LCTX) — Financial Flexibility Index
Lineage Cell Therapeutics Inc (LCTX) has a Financial Flexibility Index of -0.05x as of September 2025. Free cash flow of $-3.60 Million (operating CF $-3.62 Million minus capex $12.00K) represents 0% of total liabilities ($68.84 Million). Check LCTX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lineage Cell Therapeutics Inc Financial Flexibility Index (1991–2024)
Historical Financial Flexibility Index trend for Lineage Cell Therapeutics Inc across 34 annual periods. See LCTX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Lineage Cell Therapeutics Inc (1991–2024)
Year-by-year free cash flow to debt coverage for Lineage Cell Therapeutics Inc. For the full company profile including market capitalisation, see Lineage Cell Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.62x | $-22.53 Million | $-23.09 Million | $36.21 Million | ▲ +13.0% |
| 2023 | -0.72x | $-27.89 Million | $-28.57 Million | $39.00 Million | ▼ -2613.5% |
| 2022 | 0.03x | $1.47 Million | $1.06 Million | $51.73 Million | ▲ +110.3% |
| 2021 | -0.28x | $-23.21 Million | $-23.56 Million | $83.65 Million | ▲ +81.9% |
| 2020 | -1.54x | $-19.69 Million | $-19.75 Million | $12.82 Million | ▲ +30.6% |
| 2019 | -2.21x | $-31.51 Million | $-31.95 Million | $14.23 Million | ▲ +24.5% |
| 2018 | -2.93x | $-27.59 Million | $-30.88 Million | $9.41 Million | ▲ +9.8% |
| 2017 | -3.25x | $-29.19 Million | $-30.52 Million | $8.98 Million | ▲ +1.4% |
| 2016 | -3.30x | $-39.80 Million | $-42.33 Million | $12.06 Million | ▼ -53.2% |
| 2015 | -2.15x | $-39.21 Million | $-44.54 Million | $18.21 Million | ▲ +31.7% |
| 2014 | -3.15x | $-38.37 Million | $-38.85 Million | $12.18 Million | ▼ -79.0% |
| 2013 | -1.76x | $-27.23 Million | $-29.51 Million | $15.47 Million | ▲ +50.2% |
| 2012 | -3.53x | $-19.28 Million | $-19.68 Million | $5.45 Million | ▼ -22.3% |
| 2011 | -2.89x | $-12.63 Million | $-13.59 Million | $4.37 Million | ▼ -52.3% |
| 2010 | -1.90x | $-7.30 Million | $-7.73 Million | $3.85 Million | ▼ -7.8% |
| 2009 | -1.76x | $-4.20 Million | $-4.26 Million | $2.39 Million | ▼ -1172.3% |
| 2008 | -0.14x | $-744.37K | $-1.60 Million | $5.38 Million | ▲ +63.9% |
| 2007 | -0.38x | $-1.23 Million | $-1.24 Million | $3.22 Million | ▲ +23.0% |
| 2006 | -0.50x | $-1.25 Million | $-1.26 Million | $2.52 Million | ▲ +24.2% |
| 2005 | -0.66x | $-1.41 Million | $-1.41 Million | $2.16 Million | ▲ +49.8% |
| 2004 | -1.31x | $-1.54 Million | $-1.54 Million | $1.18 Million | ▼ -599.1% |
| 2003 | -0.19x | $-654.14K | $-654.14K | $3.50 Million | ▲ +76.6% |
| 2002 | -0.80x | $-2.13 Million | $-2.13 Million | $2.67 Million | ▲ +49.3% |
| 2001 | -1.57x | $-3.20 Million | $-3.21 Million | $2.04 Million | ▲ +88.3% |
| 2000 | -13.41x | $-4.82 Million | $-4.86 Million | $359.75K | ▼ -88.6% |
| 1999 | -7.11x | $-4.23 Million | $-4.39 Million | $595.51K | ▼ -42.2% |
| 1998 | -5.00x | $-2.00 Million | $-2.10 Million | $400.00K | ▼ -650.0% |
| 1997 | -0.67x | $-1.20 Million | $-1.30 Million | $1.80 Million | ▲ +93.7% |
| 1996 | -10.50x | $-2.10 Million | $-2.10 Million | $200.00K | ▲ +0.0% |
| 1995 | -10.50x | $-2.10 Million | $-2.10 Million | $200.00K | ▼ -121.1% |
| 1994 | -4.75x | $-1.90 Million | $-2.00 Million | $400.00K | ▲ +70.3% |
| 1993 | -16.00x | $-1.60 Million | $-1.60 Million | $100.00K | ▼ -23.1% |
| 1992 | -13.00x | $-1.30 Million | $-1.30 Million | $100.00K | ▼ -333.3% |
| 1991 | -3.00x | $-600.00K | $-600.00K | $200.00K | — |